Claim

Model ledger-default@0.1.0 ledger-strict@0.1.0 ledger-default@0.2.0 ledger-strict@0.2.0 ledger-default@0.3.0 (default) ledger-strict@0.3.0 Snapshot seq

Topics

Vaccines · 1efd24fe Public health · 1efd24fe

Assessment

Why?

Strongest counted support: The primary study reports the size of the hospitalized-child analysis set and ELISA-positive subset. weight 1.800000 evidence

Suppressed as dependent: The excerpt directly reports 2,243 hospitalized children aged 3–23 months and 638 ELISA-positive cases.

Review gaps: qualifiers reviewed, opposing search done, independence reviewed

What would most change this: One independent, direct measurement that contradicts this claim would move it from Supported to Unresolved.

Show calculation

Your view

Registered views

Checked as part of

Statements this claim was broken out of. The claim is scored on its own; a statement's reading only counts its claims.

• “A 2026 Nature Communications test-negative case-control analysis in India estimated adjusted effectiveness of the three-dose ROTASIIL rotavirus vaccine...” · 3 claims · 29 September 2026

Evidence for

• The primary study reports the size of the hospitalized-child analysis set and ELISA-positive subset.

  From Effectiveness of the oral rotavirus vaccine ROTASIIL among children hospitalized with acute gastroenteritis in India Read 2026-09-29 Relevance DIRECT Steps 0 Counted

  Primary study-population count.

• The excerpt directly reports 2,243 hospitalized children aged 3–23 months and 638 ELISA-positive cases.

  From Effectiveness of the oral rotavirus vaccine ROTASIIL among children hospitalized with acute gastroenteritis in India Read 2026-09-29 Relevance DIRECT Steps 0 Counted

Evidence against

None.

Qualifications

• The reported 2,243 denominator and 638 ELISA-positive subset are restricted to a pooled hospital-based Indian surveillance network, a defined July 2019–December 2023 period, children aged 3–23 months, and a test-negative case-control analysis.

  From Effectiveness of the oral rotavirus vaccine ROTASIIL among children hospitalized with acute gastroenteritis in India Read 2026-09-29 Relevance DIRECT Steps 0 Counted

  Clarifies the study period, Indian hospital-network jurisdiction, age and hospitalization population, pooled observational design, and positive/control denominators.

Suppressed as dependent

Evidence	Group	Kept instead
d4e7e247		37093cb8

Inferences

Concluded from

None.

Used as a premise in

None.

An inference is interpretation, not evidence: it never changes the assessment of its conclusion. Each premise is a claim with its own evidence.

Threads

None. Threads are for disagreements about how a determination was made — a statement whose figures are not in the passage it rests on, two sources that may share an origin. Something about the world belongs in the evidence above.

Claim edges

None. Edges are stored and displayed; v0.1 does not propagate probability across them.

Review checklist

Review checks: 1 of 4

2 checks by this claim's own author, alongside the independent review above. 1 QUALIFIER CHECK · 1 EVIDENCE VERIFICATION. A check by the person who recorded a claim does not raise its review coverage.

Check	Done	By
qualifiers reviewed	no
opposing search done	no
independence reviewed	no
primary source reviewed	yes	37093cb8, 4afb4bde, 31f8d98b

Summary

Contribution history

seq	event	detail
19434	APPENDED
19435	ACCEPT	AUTOMATIC_AFTER_VALIDATION
19448	LINK_EVIDENCE	by 1efd24fe (accepted)
24485	TASK_RESULT	by 1efd24fe (accepted)
25488	TASK_RESULT	by 1efd24fe (accepted)